Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


4 Ann Neurol
1 Brain
9 Diabet Med
1 Diabetes Res Clin Pract
1 Int J Clin Pract
2 J Immunol
1 J Neurol
2 J Pediatr Endocrinol Metab
3 Kidney Int
3 Lancet Neurol
5 Mult Scler
1 Neurology
5 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Neurol

  1. MAGGI P, Absinta M, Grammatico M, Vuolo L, et al
    Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
    Ann Neurol. 2018;83:283-294.
    PubMed     Text format     Abstract available

  2. AZEVEDO CJ, Cen SY, Khadka S, Liu S, et al
    Thalamic Atrophy in MS: An MRI Marker of Neurodegeneration Throughout Disease.
    Ann Neurol. 2018 Jan 12. doi: 10.1002/ana.25150.
    PubMed     Text format     Abstract available

  3. BECK ES, Reich DS
    Brain atrophy in multiple sclerosis: How deep must we go?
    Ann Neurol. 2018;83:208-209.
    PubMed     Text format    

  4. LIM JA, Lee ST, Moon J, Jun JS, et al
    Development of the Clinical Assessment Scale in Autoimmune Encephalitis (CASE).
    Ann Neurol. 2019 Jan 24. doi: 10.1002/ana.25421.
    PubMed     Text format     Abstract available


  5. CHEN Y, Podojil JR, Kunjamma RB, Jones J, et al
    Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
    Brain. 2019 Jan 17. pii: 5289373. doi: 10.1093.
    PubMed     Text format     Abstract available

    Diabet Med

  6. DYSON PA, Twenefour D, Breen C, Duncan A, et al
    Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes.
    Diabet Med. 2018 Feb 14. doi: 10.1111/dme.13603.
    PubMed     Text format     Abstract available

  7. BURKART V, Strassburger K, Zivehe F, Markgraf D, et al
    Inverse association of insulin antibody levels with insulin sensitivity in adults with Type 1 diabetes.
    Diabet Med. 2018 Feb 20. doi: 10.1111/dme.13608.
    PubMed     Text format     Abstract available

  8. AALDERS J, Hartman E, Nefs G, Nieuwesteeg A, et al
    Mindfulness and fear of hypoglycaemia in parents of children with Type 1 diabetes: results from the Diabetes MILES Youth - The Netherlands dataset.
    Diabet Med. 2018 Jan 31. doi: 10.1111/dme.13594.
    PubMed     Text format     Abstract available

  9. FORSANDER G, Stallknecht S, Samuelsson U, Marcus C, et al
    Preferences for treatment among adolescents with Type 1 diabetes: a national study using a discrete choice experiment model.
    Diabet Med. 2018 Jan 30. doi: 10.1111/dme.13592.
    PubMed     Text format     Abstract available

  10. MICHAUD S, Dasgupta K, Bell L, Yale JF, et al
    Adult care providers' perspectives on the transition to adult care for emerging adults with Type 1 diabetes: a cross-sectional survey.
    Diabet Med. 2018 Mar 25. doi: 10.1111/dme.13627.
    PubMed     Text format     Abstract available

  11. SHULMAN R, Luo J, Shah BR
    Mental health visits and low socio-economic status in adolescence are associated with complications of Type 1 diabetes in early adulthood: A population-based cohort study.
    Diabet Med. 2018 Apr 2. doi: 10.1111/dme.13633.
    PubMed     Text format     Abstract available

  12. DOLAN C, Glynn R, Griffin S, Conroy C, et al
    Brain complications of diabetes mellitus: A cross-sectional study of awareness among individuals with diabetes and the general population in Ireland.
    Diabet Med. 2018 Apr 13. doi: 10.1111/dme.13639.
    PubMed     Text format     Abstract available

  13. MUSHA I, Mochizuki M, Kikuchi T, Akatsuka J, et al
    Estimation of glycaemic control in the past month using ratio of glycated albumin to HbA1c.
    Diabet Med. 2018;35:855-861.
    PubMed     Text format     Abstract available

  14. MCEWAN P, Bennett H, Bolin K, Evans M, et al
    Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c , weight and hypoglycaemic event incidence.
    Diabet Med. 2018 Jan 27. doi: 10.1111/dme.13590.
    PubMed     Text format     Abstract available

    Diabetes Res Clin Pract

  15. GIANI E, Macedoni M, Barilli A, Petitti A, et al
    Performance of the Flash Glucose Monitoring System during exercise in youth with Type 1 diabetes.
    Diabetes Res Clin Pract. 2018;146:321-329.
    PubMed     Text format     Abstract available

    Int J Clin Pract

  16. HEALD AH, Livingston M, Fryer A, Cortes G, et al
    Real-world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes.
    Int J Clin Pract. 2018;72:e13252.
    PubMed     Text format     Abstract available

    J Immunol

  17. DORRIS ER, Tazzyman SJ, Moylett J, Ramamoorthi N, et al
    The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation.
    J Immunol. 2019 Jan 18. pii: jimmunol.1801155. doi: 10.4049/jimmunol.1801155.
    PubMed     Text format     Abstract available

  18. DI DALMAZI G, Chalan P, Caturegli P
    MYMD-1, a Novel Immunometabolic Regulator, Ameliorates Autoimmune Thyroiditis via Suppression of Th1 Responses and TNF-alpha Release.
    J Immunol. 2019 Jan 23. pii: jimmunol.1801238. doi: 10.4049/jimmunol.1801238.
    PubMed     Text format     Abstract available

    J Neurol

  19. ALCALA C, Gascon F, Perez-Miralles F, Dominguez JA, et al
    Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe.
    J Neurol. 2019 Jan 19. pii: 10.1007/s00415-019-09195.
    PubMed     Text format     Abstract available

    J Pediatr Endocrinol Metab

  20. MUNKACSI B, Papp G, Felszeghy E, Nagy BE, et al
    The associations between mental health, health-related quality of life and insulin pump therapy among children and adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2018;31:1065-1072.
    PubMed     Text format     Abstract available

  21. SZADKOWSKA A, Michalak A, Chylinska-Fratczak A, Baranowska-Jazwiecka A, et al
    Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    J Pediatr Endocrinol Metab. 2018;31:1073-1079.
    PubMed     Text format     Abstract available

    Kidney Int

  22. BOBART SA, De Vriese AS, Pawar AS, Zand L, et al
    Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Kidney Int. 2019;95:429-438.
    PubMed     Text format     Abstract available

  23. KOUSIOS A, Duncan N, Tam FWK, Chaidos A, et al
    Proliferative glomerulonephritis with monoclonal Ig deposits (PGNMID): diagnostic and treatment challenges for the nephrologist!
    Kidney Int. 2019;95:467-468.
    PubMed     Text format    

  24. WILSON HR, Medjeral-Thomas NR, Gilmore AC, Trivedi P, et al
    Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
    Kidney Int. 2019 Jan 8. pii: S0085-2538(18)30789.
    PubMed     Text format     Abstract available

    Lancet Neurol

  25. ABDELRAZEK MA, Venna N, Stone JH
    IgG4-related disease of the central and peripheral nervous systems.
    Lancet Neurol. 2018;17:183-192.
    PubMed     Text format     Abstract available

  26. CICCARELLI O, Cohen JA, Reingold SC, Weinshenker BG, et al
    Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lancet Neurol. 2019;18:185-197.
    PubMed     Text format     Abstract available

  27. FILIPPI M, Bruck W, Chard D, Fazekas F, et al
    Association between pathological and MRI findings in multiple sclerosis.
    Lancet Neurol. 2019;18:198-210.
    PubMed     Text format     Abstract available

    Mult Scler

  28. VAN MUNSTER CE, Kaya L, Obura M, Kalkers NF, et al
    Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).
    Mult Scler. 2019 Jan 18:1352458518823489. doi: 10.1177/1352458518823489.
    PubMed     Text format     Abstract available

  29. VALENCIA-SANCHEZ C, Goodman BP, Carter JL, Wingerchuk DM, et al
    The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations.
    Mult Scler. 2019 Jan 18:1352458518823482. doi: 10.1177/1352458518823482.
    PubMed     Text format     Abstract available

  30. CORDANI C, Meani A, Esposito F, Valsasina P, et al
    Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study.
    Mult Scler. 2019 Jan 18:1352458518822145. doi: 10.1177/1352458518822145.
    PubMed     Text format     Abstract available

  31. STORK L, Bruck W, von Gottberg P, Pulkowski U, et al
    Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.
    Mult Scler. 2019 Jan 18:1352458518819098. doi: 10.1177/1352458518819098.
    PubMed     Text format     Abstract available

  32. SECHI E, Flanagan EP
    Area postrema syndrome in autoimmune GFAP astrocytopathy.
    Mult Scler. 2019 Jan 21:1352458519826489. doi: 10.1177/1352458519826489.
    PubMed     Text format    


  33. COHEN J, Sotoca J, Gandhi S, Yeshokumar AK, et al
    Autoimmune encephalitis: A costly condition.
    Neurology. 2019 Jan 23. pii: WNL.0000000000006990.
    PubMed     Text format     Abstract available

    PLoS One

  34. KERVINEN MH, Lehto S, Helve J, Gronhagen-Riska C, et al
    Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation.
    PLoS One. 2018;13:e0201478.
    PubMed     Text format     Abstract available

  35. CUMMINGS M, Arumanayagam ACS, Zhao P, Kannanganat S, et al
    Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0200752.
    PubMed     Text format     Abstract available

  36. CASANA-GRANELL S, Lacomba-Trejo L, Valero-Moreno S, Prado-Gasco V, et al
    A brief version of the Pediatric Inventory for Parents (PIP) in Spanish population: Stress of main family carers of chronic paediatric patients.
    PLoS One. 2018;13:e0201390.
    PubMed     Text format     Abstract available

  37. SAIRANEN E, Lappalainen P, Hiltunen A
    Psychological inflexibility explains distress in parents whose children have chronic conditions.
    PLoS One. 2018;13:e0201155.
    PubMed     Text format     Abstract available

  38. ZHERNAKOVA DV, Kliver S, Cherkasov N, Tamazian G, et al
    Analytical "bake-off" of whole genome sequencing quality for the Genome Russia project using a small cohort for autoimmune hepatitis.
    PLoS One. 2018;13:e0200423.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.